Next Generation News and Research

RSS

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Cypher Genomics, Inc., the leading genome informatics company, and Sequenom, Inc., the leading molecular diagnostics company, today announced a development agreement for next generation noninvasive prenatal tests (NIPT).

22 Jan 2015

K2M obtains FDA approval to market MESA 2 Deformity Spinal System

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the MESA 2 Deformity Spinal System.

22 Jan 2015

Study identifies gene that may become resistant to current testicular cancer treatments

A major research study has uncovered several new genetic mutations that could drive testicular cancer - and also identified a gene which may contribute to tumours becoming resistant to current treatments.

22 Jan 2015

CUMC researcher develops new 3D microscope that can help view living things at very high speeds

Opening new doors for biomedical and neuroscience research, Elizabeth Hillman, associate professor of biomedical engineering at Columbia Engineering and of radiology at Columbia University Medical Center, has developed a new microscope that can image living things in 3D at very high speeds.

20 Jan 2015

JHU Applied Physics Laboratory awarded $4 million to develop retinal prosthesis system

The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.

16 Jan 2015

New study characterizes genetic underpinnings of phyllodes tumors

A new study from researchers at the University of Michigan Comprehensive Cancer Center characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.

16 Jan 2015

ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

ArborMetrix, Inc., a leading provider of cloud-based healthcare analytics solutions, today announced that the Urology Department of the University of North Carolina School of Medicine is using its cloud-based RegistryMetrix analytics platform.

15 Jan 2015

CAR T-cell therapy enters into Phase I clinical trial

Cancer fighting chimeric antigen receptor (CAR) T cells, developed in the Sentman laboratory of Dartmouth's Norris Cotton Cancer Center, are taking the next step into a Phase I clinical trial beginning early in 2015.

15 Jan 2015

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

University Hospitals Case Medical Center has signed an agreement with Advanced Biological Laboratories, an information technology and diagnostic company based in Luxembourg, to join efforts on the designing and validation of an HIV drug resistance and tropism assay based on next-generation sequencing (NGS).

14 Jan 2015

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Sophia Genetics, the European leader in Data Driven Medicine, has today obtained CE-IVD marking for its solution to detect BRCA1/2 associated genetic variants in live tumours.

14 Jan 2015

Doximity names UC San Diego School of Medicine among nation's top residency training programs

UC San Diego School of Medicine was today named one of the nation's top residency training programs in 10 specialties by Doximity. The Doximity report included more than 50,000 peer nominations from board-certified US physicians, and evaluated 3,691 residency training programs across 20 specialties.

14 Jan 2015

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies.

14 Jan 2015

Valorem Surgical reports FDA approval and first utilization of MaxiMIS Spinal Fixation System

Valorem Surgical, an early stage medical device company with a platform on surgically treating spinal pathologies through a minimally invasive (MIS) approach, today announced that the Company has received FDA clearance and its first case utilizing its minimally invasive MaxiMIS Spinal Fixation System, performed by board-certified, neurosurgeon, Dr. Jae Lim in Reston, VA.

13 Jan 2015

HealthLoop releases new doctor-patient engagement app

HealthLoop released a new app of its doctor-patient engagement platform today. HealthLoop+ MD is another step forward in bringing the latest technology and innovation of next generation follow-up care to doctors and patients.

13 Jan 2015

Beckman Coulter Genomics announces CAP accreditation

Beckman Coulter Genomics, a leading provider of DNA Sequencing Services announces today accreditation from the College of American Pathologists (CAP).

From Beckman Coulter Life Sciences - Automation and Genomics 13 Jan 2015

EGFR mutations, ALK translocations not mutually exclusive in NSCLC

Researchers from the Republic of Korea have found that epidermal growth factor receptor mutations and anaplastic lymphoma kinase translocations can occur concomitantly in a proportion of patients with non-small-cell lung cancer.

12 Jan 2015

Blast phase characteristics differ in TKI-, non-TKI–treated CML patients

Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.

12 Jan 2015

HLI gains access to PGDx's cancer genomics solutions to expand cancer genome analysis

Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc., the human health information technology and health care company, today announced that HLI will have access to PGDx's cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete.

12 Jan 2015

ACS announces launch of new initiative to increase membership

Today the American College of Surgeons announced the launch of a new initiative aimed at stimulating more young surgeons (defined as under the age of 45) to become involved in the organization and increase membership.

8 Jan 2015

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

1 Jan 2015

Next Generation News and Research

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

K2M obtains FDA approval to market MESA 2 Deformity Spinal System

Study identifies gene that may become resistant to current testicular cancer treatments

CUMC researcher develops new 3D microscope that can help view living things at very high speeds

JHU Applied Physics Laboratory awarded $4 million to develop retinal prosthesis system

New study characterizes genetic underpinnings of phyllodes tumors

ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

CAR T-cell therapy enters into Phase I clinical trial

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Doximity names UC San Diego School of Medicine among nation's top residency training programs

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Valorem Surgical reports FDA approval and first utilization of MaxiMIS Spinal Fixation System

HealthLoop releases new doctor-patient engagement app

Beckman Coulter Genomics announces CAP accreditation

EGFR mutations, ALK translocations not mutually exclusive in NSCLC

Blast phase characteristics differ in TKI-, non-TKI–treated CML patients

HLI gains access to PGDx's cancer genomics solutions to expand cancer genome analysis

ACS announces launch of new initiative to increase membership

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News